Un abonnement à JoVE est nécessaire pour voir ce contenu. Connectez-vous ou commencez votre essai gratuit.
Chapitres
- 00:04Introduction
- 00:39In Vitro HAT Assay
- 01:37ChHAI Assay
- 03:11Chromatin Immunoprecipitation (ChIP)
- 05:48Results: Inhibitors of Histone Acetyltransferases
- 08:19Conclusion
Inhibitors of histone acetyltransferases (HATs, also known as lysine acetyltransferases), such as CBP/p300, are potential therapeutics for treating cancer. However, rigorous methods for validating these inhibitors are needed. Three in vitro methods for validation include HAT assays with recombinant acetyltransferases, immunoblotting for histone acetylation in cell culture, and ChIP-qPCR.
